Basic studies on radioimmunotargeting of CD133-positive HCT116 cancer stem cells

Molecular Imaging

Volumn 11, Issue 6, 2012, Pages 445-450

  Jin, Zhao Hui ^b   Sogawa, Chizuru ^b   Furukawa, Takako ^a   Saito, Yuriko ^b   Aung, Winn ^b   Fujibayashi, Yasuhisa ^b   Saga, Tsuneo ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELLS; CANCER DEVELOPMENT; CANCER STEM CELLS; EXPRESSION PATTERNS; IMMUNOREACTIVITIES; IN-VITRO; IN-VIVO;

BINDING ENERGY; BIOLOGICAL MATERIALS; CELL MEMBRANES; CYTOLOGY; DISEASES; STEM CELLS;

ANTIBODIES;

ANTIBODY CONJUGATE; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BAGG ALBINO MOUSE; CANCER STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MOUSE; NUDE MOUSE; RADIATION EXPOSURE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; AUTORADIOGRAPHY; CELL LINE, TUMOR; GLYCOPROTEINS; HUMANS; IMMUNOCONJUGATES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; PEPTIDES; TISSUE DISTRIBUTION;

EID: 84873923542     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2012.00008     Document Type: Article

References (16)

1. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011;17:313-9, doi:10.1038/nm.2304.
2. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006;66:1883-90, doi:10.1158/0008-5472.CAN-05-3153.
3. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006;355:1253-61, doi:10.1056/NEJMra061808.
4. Takebe N, Harris PJ, Warren RQ, et al. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 2011;8:97-106, doi:10.1038/nrclinonc.2010.196.
5. Wang Y, Krivtsov AV, Sinha AU, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010;327:1650-3, doi:10.1126/science.1186624.
6. Wu C, Alman BA. Side population cells in human cancers. Cancer Lett 2008;268:1-9, doi:10.1016/j.canlet.2008.03.048.
7. Hadnagy A, Gaboury L, Beaulieu R, et al. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006;312: 3701-10.
8. Keysar SB, Jimeno A. More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther 2010;9: 2450-7, doi:10.1158/1535-7163.MCT-10-0530.
9. Cui X, Oonishi K, Tsujii H, et al. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res 2011;71:3676-87, doi:10.1158/0008-5472.CAN-10-2926.
10. Dittfeld C, Dietrich A, Peickert S, et al. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116. Radiother Oncol 2010;94:375-83, doi:10.1016/j.radonc.2009.10. 010.
11. Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118: 2111-20.
12. Tsurumi C, Esser N, Firat E, et al. Non-invasive in vivo imaging of tumor-associated CD133/prominin. PLoS One 2010;5:e15605, doi:10.1371/journal. pone.0015605.
13. Campos B, Zeng L, Daotrong PH, et al. Expression and regulation of AC133 and CD133 in glioblastoma. Glia 2011;59:1974-86, doi:10.1002/glia.21239.
14. Burvenich I, Schoonooghe S, Cornelissen B, et al. In vitro and in vivo targeting properties of iodine-123-or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. Clin Cancer Res 2005;11:7288-96, doi:10.1158/1078-0432.CCR-04-2503.
15. Steffens MG, Oosterwijk E, Kranenborg MH, et al. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med 1999;40:829-36.
16. Yao Z, Sakahara H, Zhang M, et al. Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody. Nucl Med Biol 1995;22:199-203, doi:10.1016/0969-8051(94)00092-X.